Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2001
Business Overview: The Company provides Gamma Knife units to medical centers through its majority-owned subsidiary, GK Financing, LLC. As of June 30, 2001, the Company operated 12 Gamma Knife units across 11 states. Revenue models include fee-per-use contracts and revenue-sharing ("retail") agreements.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2001 | Six Months Ended June 30, 2001 |
|---|---|---|
| Revenues (Medical Services) | $2,819,000 | $5,679,000 |
| Net Income | $186,000 | $603,000 |
| Earnings Per Share (Basic) | $0.05 | $0.17 |
| Operating Cash Flow | N/A | $2,295,000 |
| Cash and Cash Equivalents | $11,781,000 (Balance Sheet) | $11,781,000 (Balance Sheet) |
| Total Debt (Current + Long-term) | $26,161,000 | $26,161,000 |
| Working Capital | $8,695,000 | $8,695,000 |
Material Changes vs. Prior Period
- Revenue Growth: Medical services revenue increased 36% for the six months ended June 30, 2001, compared to the prior year. This was driven by the addition of three new Gamma Knife units (totaling 12 units) and a 13% increase in revenue from existing units.
- Profitability: Net income for the six months ended June 30, 2001, rose to $603,000 from $527,000 in the prior year. However, this growth was partially offset by a new 40% income tax provision recorded in the second quarter of 2001 (no tax expense was recorded in 2000 due to net operating loss carryforwards).
- Expense Increases:
- Costs of Operations: Increased due to higher maintenance costs (9 units under contract vs. 4 in 2000), depreciation from new units, and higher insurance/marketing expenses.
- Selling and Administrative: Increased by $322,000 for the six-month period, primarily due to investor relations costs and $154,000 in development costs for startup businesses OR21 and MedLeader.
- Interest Expense: Increased by $179,000 for the six-month period due to financing for new units.
- Interest Income: Decreased by $146,000 for the six-month period due to lower interest rates on invested cash and a reduction in state tax refunds compared to the prior year.
Guidance, Outlook, and Risks
- Liquidity: The Company holds $11.8 million in cash and cash equivalents. Management believes cash flow from operations and existing resources are adequate to meet scheduled debt obligations of approximately $7.3 million due in the next 12 months.
- Capital Allocation: During the six-month period, the Company paid its first annual dividend ($0.10 per share, totaling $361,000), repurchased 165,000 shares of common stock and 69,000 options ($490,000 total), and made $500,000 in deposits for future Gamma Knife purchases.
- Tax Outlook: The Company expects to continue recording an estimated 40% income tax provision for the remainder of the year.
- Legal Proceedings: No material legal proceedings were reported.
Investor Verification Checklist
- Unit Utilization: Verify the utilization rates of the three new Gamma Knife units added in 2001 to ensure they meet revenue projections.
- Startup Costs: Monitor the burn rate and development progress of the startup subsidiaries OR21 and MedLeader, which contributed $154,000 in costs for the six-month period.
- Debt Servicing: Confirm the Company's ability to service $7.3 million in scheduled debt payments over the next 12 months given the current cash position.
- Tax Provision: Validate the sustainability of the 40% income tax provision and the status of net operating loss carryforwards.
- Share Count: Note the reduction in outstanding shares due to repurchases (3,554,125 shares outstanding as of July 19, 2001) and its impact on future EPS.